Inducing Oncoprotein Degradation to Improve Targeted Cancer Therapy

by Dipankar Ray, Kyle C. Cuneo, Alnawaz Rehemtulla, Theodore S. Lawrence, Mukesh K. Nyati
Published 2015-09-01

Enhancing the Radiation Response in KRAS Mutant Colorectal Cancers Using the c-Met Inhibitor Crizotinib

by Kyle C. Cuneo, Ranjit K. Mehta, Himabindu Kurapati, Dafydd G. Thomas, Theodore S. Lawrence, Mukesh K. Nyati
Published 2019-02-01

Low Dose Rate Radiosensitization of Hepatocellular Carcinoma In Vitro and in Patients

by Kyle C. Cuneo, Mary A. Davis, Mary U. Feng, Paula M. Novelli, William D. Ensminger, Theodore S. Lawrence
Published 2014-08-01

Expansion of Circulating Tumor Cells from Patients with Locally Advanced Pancreatic Cancer Enable Patient Derived Xenografts and Functional Studies for Personalized Medicine

by Lianette Rivera-Báez, Ines Lohse, Eric Lin, Shreya Raghavan, Sarah Owen, Ramdane Harouaka, Kirk Herman, Geeta Mehta, Theodore S. Lawrence, Meredith A. Morgan, Kyle C. Cuneo, Sunitha Nagrath
Published 2020-04-01

Serum Levels of Hepatocyte Growth Factor and CD40 Ligand Predict Radiation-Induced Liver Injury

by Kyle C. Cuneo, Theresa Devasia, Yilun Sun, Matthew J. Schipper, David Karnak, Mary A. Davis, Dawn Owen, Mary Feng, Issam El Naqa, Latifa Bazzi, Randy Ten Haken, Theodore S. Lawrence
Published 2019-07-01

Impact of 90Y PET gradient-based tumor segmentation on voxel-level dosimetry in liver radioembolization

by Justin K. Mikell, Ravi K. Kaza, Peter L. Roberson, Kelly C. Younge, Ravi N. Srinivasa, Bill S. Majdalany, Kyle C. Cuneo, Dawn Owen, Theresa Devasia, Matthew J. Schipper, Yuni K. Dewaraja
Published 2018-11-01

TNFR1 and the TNFα axis as a targetable mediator of liver injury from stereotactic body radiation therapy

by Matthew M. Cousins, Emily Morris, Christopher Maurino, Theresa P. Devasia, David Karnak, Dipankar Ray, Neehar D. Parikh, Dawn Owen, Randall K. Ten Haken, Matthew J. Schipper, Theodore S. Lawrence, Kyle C. Cuneo
Published 2021-01-01

A Pilot Study of Diffusion-Weighted MRI in Patients Undergoing Neoadjuvant Chemoradiation for Pancreatic Cancer

by Kyle C. Cuneo, Thomas L. Chenevert, Edgar Ben-Josef, Mary U. Feng, Joel K. Greenson, Hero K. Hussain, Diane M. Simeone, Matthew J. Schipper, Michelle A. Anderson, Mark M. Zalupski, Mahmoud Al-Hawary, Craig J. Galban, Alnawaz Rehemtulla, Felix Y. Feng, Theodore S. Lawrence, Brian D. Ross
Published 2014-10-01

Neoadjuvant twice daily chemoradiotherapy for esophageal cancer: Treatment-related mortality and long-term outcomes

by Stuart E. Samuels, MD, PhD, Matthew H. Stenmark, MD, Jae Y. Lee, MD, PhD, Jonathan B. McHugh, MD, James A. Hayman, MD, Mark B. Orringer, MD, Susan G. Urba, MD, Libin Sun, MD, Congying Xie, PhD, Feng-Ming Kong, MD, PhD, Kyle C. Cuneo, MD
Published 2017-07-01